IMNM stock

Immunome Inc (IMNM) financials · rev $6.9M

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Immunome Inc (IMNM) rev $6.9M.

Cached annual income statement
LineFY2025FY2024
Revenue$6.94M$9.04M
Operating Income-$224.1M-$305.8M
Net Income-$212.4M-$293.0M
EPS (Diluted)-$2.43N/A
Cached annual balance sheet
LineFY2025FY2024
Total Assets$683.2M$240.2M
Current Assets$660.8M$221.3M
Cash & Equivalents$653.5M$143.4M
PP&E$14.6M$10.1M
Total Liabilities$48.8M$59.1M
Current Liabilities$45.0M$54.3M
Shareholders' Equity$634.3M$181.2M
Retained Earnings-$728.2M-$515.8M
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$190.9M-$110.8M
CapEx$9.69M$7.17M
Investing Cash Flow$60.8M-$85.1M
Financing Cash Flow$640.4M$240.5M
Net Change in Cash$510.2M$44.7M
Free Cash Flow-$200.6M-$118.0M
These statements as JSON? API free 100/day

FAQ

What is IMNM P/E and revenue?

Immunome Inc (IMNM) rev $6.9M.

What is IMNM revenue?

Immunome Inc last cached revenue is $6.94M (FY2025).

Is IMNM profitable?

Immunome Inc last cached net income is -$212.4M (FY2025).

What are IMNM total assets?

Immunome Inc last cached total assets are $683.2M (FY2025).

What is IMNM free cash flow?

Immunome Inc last cached free cash flow is -$200.6M (FY2025).

Not investment advice. Cached statements, not a live tape.